{"DataElement":{"publicId":"3745017","version":"1","preferredName":"Non-Small Cell Lung Cancer American Joint Committee on Cancer (AJCC) Edition 7 Group Stage","preferredDefinition":"Stage group determined from information on the tumor (T), regional node (N) and metastases (M) and by grouping cases with similar prognosis for non-small cell lung carcinoma.","longName":"3745006v1.0:3744984v1.0","context":"NCI Standards","contextVersion":"1","DataElementConcept":{"publicId":"3745006","version":"1","preferredName":"Non-Small Cell Lung Cancer Stage Grouping","preferredDefinition":"A group of at least three distinct histological types of lung cancer, including squamous cell carcinoma, adenocarcinoma, and large cell carcinoma.  Non-small cell lung carcinomas have a poor response to conventional chemotherapy.  --2002_An assessment based on the combined evaluation of the patient's T stage, M stage, and N stage.","longName":"2442986v1.0:2230143v1.0","context":"NCI Standards","contextVersion":"1","ObjectClass":{"publicId":"2442986","version":"1","preferredName":"NSCLC","preferredDefinition":"A group of at least three distinct histological types of lung cancer, including squamous cell carcinoma, adenocarcinoma, and large cell carcinoma.  Non-small cell lung carcinomas have a poor response to conventional chemotherapy.  --2002","longName":"C2926","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Lung Non-Small Cell Carcinoma","conceptCode":"C2926","definition":"A group of at least three distinct histological types of lung cancer, including non-small cell squamous cell carcinoma, adenocarcinoma, and large cell carcinoma. Non-small cell lung carcinomas have a poor response to conventional chemotherapy.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0A2C1D25-889A-603A-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-01-12","endDate":null,"createdBy":"SHIDED","dateCreated":"2006-01-12","modifiedBy":"ONEDATA","dateModified":"2006-01-12","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2230143","version":"1","preferredName":"Stage Grouping","preferredDefinition":"Stage Grouping; an assessment based on the combined evaluation of the patient's T stage, M stage, and N stage. (caDSR)","longName":"C38027","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage Grouping","conceptCode":"C38027","definition":"An assessment based on the combined evaluation of the patient's T stage, M stage, and N stage, as well as prognostic parameters for specific cancers.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F752037A-4CC2-36A8-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-05-18","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-05-18","modifiedBy":"ONEDATA","dateModified":"2005-05-18","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"DC2367C9-00E9-2766-E040-BB89AD437A4E","latestVersionIndicator":"Yes","beginDate":"2013-05-07","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-05-07","modifiedBy":"TAYLORT","dateModified":"2017-09-13","changeDescription":"9/13/17 tt transferred context; changed def - 1st letter upper case; changed Reg Status to Qualified. Created for CRF Harmonization per request D.Reeves for Duke U. mc 5/6/13","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"3744984","version":"1","preferredName":"Non-Small Cell Lung Cancer American Joint Committee on Cancer Edition 7 Group Stage","preferredDefinition":"A group of at least three distinct histological types of lung cancer, including squamous cell carcinoma, adenocarcinoma, and large cell carcinoma.  Non-small cell lung carcinomas have a poor response to conventional chemotherapy.  --2002_A group formed for the purpose of developing a system of clinical staging for cancer that is acceptable to the American medical profession and is compatible with other accepted classifications._An assessment based on the combined evaluation of the patient's T stage, M stage, and N stage._The extent of a cancer within the body, especially whether the disease has spread from the original site to other parts of the body.","longName":"3744984v1.0","context":"NCIP","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":"1","maxLength":"13","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Stage unknown","valueDescription":"Stage Unknown","ValueMeaning":{"publicId":"3357508","version":"1","preferredName":"Stage Unknown","longName":"3357508","preferredDefinition":"A finding indicating that the extent of organ/tissue involvement by a malignant neoplasm is not reported or not assessed.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage Unknown","conceptCode":"C92207","definition":"The extent of organ/tissue involvement by a malignant neoplasm is not reported or not assessed.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B6D76279-6263-2CA8-E040-BB89AD434A54","latestVersionIndicator":"Yes","beginDate":"2012-01-18","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-01-18","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"DC2367C8-FF53-2766-E040-BB89AD437A4E","beginDate":"2013-05-07","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-05-07","modifiedBy":"ONEDATA","dateModified":"2013-05-07","deletedIndicator":"No"},{"value":"IV","valueDescription":"Stage IV Non-Small Cell Lung Cancer","ValueMeaning":{"publicId":"3744986","version":"1","preferredName":"Stage IV Non-Small Cell Lung Cancer","longName":"3744986","preferredDefinition":"Stage IV includes: (Any T, Any N, M1a); (Any T, Any N, M1b).  M1a: Lung cancer with separate tumor nodule(s) in a contralateral lobe; tumor with pleural nodules or malignant pleural (or pericardial) effusion.  M1b: Distant metastasis. (AJCC 7th ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage IV Lung Non-Small Cell Cancer AJCC v7","conceptCode":"C4012","definition":"Stage IV includes: (Any T, Any N, M1a); (Any T, Any N, M1b).  M1a: Lung cancer with separate tumor nodule(s) in a contralateral lobe; tumor with pleural nodules or malignant pleural (or pericardial) effusion.  M1b: Distant metastasis. (AJCC 7th ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"DC2367C8-FF60-2766-E040-BB89AD437A4E","latestVersionIndicator":"Yes","beginDate":"2013-05-07","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-05-07","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"DC2367C8-FF79-2766-E040-BB89AD437A4E","beginDate":"2013-05-07","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-05-07","modifiedBy":"ONEDATA","dateModified":"2013-05-07","deletedIndicator":"No"},{"value":"IIIB","valueDescription":"Stage IIIB Non-Small Cell Lung Cancer","ValueMeaning":{"publicId":"3744988","version":"1","preferredName":"Stage IIIB Non-Small Cell Lung Cancer","longName":"3744988","preferredDefinition":"Stage IIIB includes: (T1a, N3, M0); (T1b, N3, M0); (T2a, N3, M0); (T2b, N3, M0); (T3, N3, M0); (T4, N2, M0); (T4, N3, M0).  T4: Lung cancer with a tumor of any size that invades any of the following: mediastinum, heart, great vessels, trachea, recurrent laryngeal nerve, esophagus, vertebral body, carina, and separate tumor nodule(s) in a different ipsilateral lobe.  N2: Lung cancer with metastasis to ipsilateral mediastinal and/or subcarinal lymph nodes.  N3: Lung cancer with metastasis to contralateral mediastinal, contralateral hilar, ipsilateral or contralateral scalene, or supraclavicular lymph nodes.  M0: No distant metastasis. (AJCC 7th ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage IIIB Lung Non-Small Cell Cancer AJCC v7","conceptCode":"C9103","definition":"Stage IIIB includes: (T1a, N3, M0); (T1b, N3, M0); (T2a, N3, M0); (T2b, N3, M0); (T3, N3, M0); (T4, N2, M0); (T4, N3, M0).  T4: Lung cancer with a tumor of any size that invades any of the following: mediastinum, heart, great vessels, trachea, recurrent laryngeal nerve, esophagus, vertebral body, carina, and separate tumor nodule(s) in a different ipsilateral lobe.  N2: Lung cancer with metastasis to ipsilateral mediastinal and/or subcarinal lymph nodes.  N3: Lung cancer with metastasis to contralateral mediastinal, contralateral hilar, ipsilateral or contralateral scalene, or supraclavicular lymph nodes.  M0: No distant metastasis. (AJCC 7th ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"DC2367C8-FF86-2766-E040-BB89AD437A4E","latestVersionIndicator":"Yes","beginDate":"2013-05-07","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-05-07","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"DC2367C8-FF9F-2766-E040-BB89AD437A4E","beginDate":"2013-05-07","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-05-07","modifiedBy":"ONEDATA","dateModified":"2013-05-07","deletedIndicator":"No"},{"value":"IIIA","valueDescription":"Stage IIIA Non-Small Cell Lung Cancer","ValueMeaning":{"publicId":"3744990","version":"1","preferredName":"Stage IIIA Non-Small Cell Lung Cancer","longName":"3744990","preferredDefinition":"Stage IIIA includes: (T1a, N2, M0); (T1b, N2, M0); (T2a, N2, M0); (T2b, N2, M0); (T3, N1, M0); (T3, N2, M0); (T4, N0, M0); (T4, N1, M0).  T4: Lung cancer with a tumor of any size that invades any of the following: mediastinum, heart, great vessels, trachea, recurrent laryngeal nerve, esophagus, vertebral body, carina, and separate tumor nodule(s) in a different ipsilateral lobe.  N1: Lung cancer with metastasis in ipsilateral peribronchial and/or ipsilateral hilar lymph nodes and intrapulmonary lymph nodes, including involvement by direct extension.  N2: Lung cancer with metastasis to ipsilateral mediastinal and/or subcarinal lymph nodes.  M0: No distant metastasis. (AJCC 7th ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage IIIA Lung Non-Small Cell Cancer AJCC v7","conceptCode":"C9102","definition":"Stage IIIA includes: (T1a, N2, M0); (T1b, N2, M0); (T2a, N2, M0); (T2b, N2, M0); (T3, N1, M0); (T3, N2, M0); (T4, N0, M0); (T4, N1, M0).  T4: Lung cancer with a tumor of any size that invades any of the following: mediastinum, heart, great vessels, trachea, recurrent laryngeal nerve, esophagus, vertebral body, carina, and separate tumor nodule(s) in a different ipsilateral lobe.  N1: Lung cancer with metastasis in ipsilateral peribronchial and/or ipsilateral hilar lymph nodes and intrapulmonary lymph nodes, including involvement by direct extension.  N2: Lung cancer with metastasis to ipsilateral mediastinal and/or subcarinal lymph nodes.  M0: No distant metastasis. (AJCC 7th ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"DC2367C8-FFAC-2766-E040-BB89AD437A4E","latestVersionIndicator":"Yes","beginDate":"2013-05-07","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-05-07","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"DC2367C8-FFC5-2766-E040-BB89AD437A4E","beginDate":"2013-05-07","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-05-07","modifiedBy":"ONEDATA","dateModified":"2013-05-07","deletedIndicator":"No"},{"value":"IIB","valueDescription":"Stage IIB Non-Small Cell Lung Carcinoma","ValueMeaning":{"publicId":"3744992","version":"1","preferredName":"Stage IIB Non-Small Cell Lung Carcinoma","longName":"3744992","preferredDefinition":"Stage IIB includes: (T2b, N1, M0); (T3, N0, M0).  T2b: Lung cancer with a tumor size more than 5 cm but 7 cm or less in greatest dimension.  T3: Lung cancer with a tumor size more than 7 cm or one that directly invades any of the following: parietal pleural (PL3) chest wall (including superior sulcus tumors), diaphragm, phrenic nerve, mediastinal pleura, parietal pericardium; or tumor in the main bronchus (less than 2 cm distal to the carina but without involvement of the carina); or associated atelectasis or obstructive pneumonitis of the entire lung or separate tumor nodule(s) in the same lobe. N0: No regional lymph node metastasis.  N1: Lung cancer with metastasis in ipsilateral peribronchial and/or ipsilateral hilar lymph nodes and intrapulmonary lymph nodes, including involvement by direct extension. M0: No distant metastasis. (AJCC 7th ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage IIB Lung Non-Small Cell Carcinoma AJCC v7","conceptCode":"C5654","definition":"Stage IIB includes: (T2b, N1, M0); (T3, N0, M0).  T2b: Lung cancer with a tumor size more than 5 cm but 7 cm or less in greatest dimension.  T3: Lung cancer with a tumor size more than 7 cm or one that directly invades any of the following: parietal pleural (PL3) chest wall (including superior sulcus tumors), diaphragm, phrenic nerve, mediastinal pleura, parietal pericardium; or tumor in the main bronchus (less than 2 cm distal to the carina but without involvement of the carina); or associated atelectasis or obstructive pneumonitis of the entire lung or separate tumor nodule(s) in the same lobe. N0: No regional lymph node metastasis.  N1: Lung cancer with metastasis in ipsilateral peribronchial and/or ipsilateral hilar lymph nodes and intrapulmonary lymph nodes, including involvement by direct extension. M0: No distant metastasis. (AJCC 7th ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"DC2367C8-FFD2-2766-E040-BB89AD437A4E","latestVersionIndicator":"Yes","beginDate":"2013-05-07","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-05-07","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"DC2367C8-FFEB-2766-E040-BB89AD437A4E","beginDate":"2013-05-07","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-05-07","modifiedBy":"ONEDATA","dateModified":"2013-05-07","deletedIndicator":"No"},{"value":"IIA","valueDescription":"Stage IIA Non-Small Cell Lung Carcinoma","ValueMeaning":{"publicId":"3744994","version":"1","preferredName":"Stage IIA Non-Small Cell Lung Carcinoma","longName":"3744994","preferredDefinition":"Stage IIA includes: (T2b, N0, M0); (T1a, N1, M0); (T1b, N1, M0); (T2a, N1, M0).  T2b: Lung cancer with a tumor size more than 5 cm but 7 cm or less in greatest dimension.  T1a: Lung cancer with a tumor size of 2 cm or less in greatest dimension, surrounded by lung or visceral pleura and without bronchoscopic evidence of invasion more proximal than the lobar bronchus (i.e., not in the main bronchus). The uncommon superficial tumor of any size with its invasive component limited to the bronchial wall, which may extend proximal to the main bronchus, is also classified as T1a.  T1b: Lung cancer with a tumor size more than 2 cm but 3 cm or less in greatest dimension, surrounded by lung or visceral pleura and without bronchoscopic evidence of invasion more proximal than the lobar bronchus (i.e., not in the main bronchus).  T2a: Lung cancer with a tumor size more than 3 cm but 5 cm or less in greatest dimension.  N0: No regional lymph node metastasis.  N1: Lung cancer with metastasis in ipsilateral peribronchial and/or ipsilateral hilar lymph nodes and intrapulmonary lymph nodes, including involvement by direct extension. M0: No distant metastasis. (AJCC 7th ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage IIA Lung Non-Small Cell Carcinoma AJCC v7","conceptCode":"C5655","definition":"Stage IIA includes: (T2b, N0, M0); (T1a, N1, M0); (T1b, N1, M0); (T2a, N1, M0).  T2b: Lung cancer with a tumor size more than 5 cm but 7 cm or less in greatest dimension.  T1a: Lung cancer with a tumor size of 2 cm or less in greatest dimension, surrounded by lung or visceral pleura and without bronchoscopic evidence of invasion more proximal than the lobar bronchus (i.e., not in the main bronchus). The uncommon superficial tumor of any size with its invasive component limited to the bronchial wall, which may extend proximal to the main bronchus, is also classified as T1a.  T1b: Lung cancer with a tumor size more than 2 cm but 3 cm or less in greatest dimension, surrounded by lung or visceral pleura and without bronchoscopic evidence of invasion more proximal than the lobar bronchus (i.e., not in the main bronchus).  T2a: Lung cancer with a tumor size more than 3 cm but 5 cm or less in greatest dimension.  N0: No regional lymph node metastasis.  N1: Lung cancer with metastasis in ipsilateral peribronchial and/or ipsilateral hilar lymph nodes and intrapulmonary lymph nodes, including involvement by direct extension. M0: No distant metastasis. (AJCC 7th ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"DC2367C8-FFF8-2766-E040-BB89AD437A4E","latestVersionIndicator":"Yes","beginDate":"2013-05-07","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-05-07","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"DC2367C9-0011-2766-E040-BB89AD437A4E","beginDate":"2013-05-07","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-05-07","modifiedBy":"ONEDATA","dateModified":"2013-05-07","deletedIndicator":"No"},{"value":"IB","valueDescription":"Stage IB Non-Small Cell Lung Carcinoma","ValueMeaning":{"publicId":"3744996","version":"1","preferredName":"Stage IB Non-Small Cell Lung Carcinoma","longName":"3744996","preferredDefinition":"Stage IB includes: T2a, N0, M0.  T2a: Lung cancer with a tumor size more than 3 cm but 5 cm or less in greatest dimension.  N0: No regional lymph metastasis.  M0: No distant metastasis. (AJCC 7th ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage IB Lung Non-Small Cell Carcinoma AJCC v7","conceptCode":"C5653","definition":"Stage IB includes: T2a, N0, M0.  T2a: Lung cancer with a tumor size more than 3 cm but 5 cm or less in greatest dimension.  N0: No regional lymph metastasis.  M0: No distant metastasis. (AJCC 7th ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"DC2367C9-001E-2766-E040-BB89AD437A4E","latestVersionIndicator":"Yes","beginDate":"2013-05-07","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-05-07","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"DC2367C9-0037-2766-E040-BB89AD437A4E","beginDate":"2013-05-07","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-05-07","modifiedBy":"ONEDATA","dateModified":"2013-05-07","deletedIndicator":"No"},{"value":"IA","valueDescription":"Stage IA Non-Small Cell Lung Carcinoma","ValueMeaning":{"publicId":"3744998","version":"1","preferredName":"Stage IA Non-Small Cell Lung Carcinoma","longName":"3744998","preferredDefinition":"Stage IA includes: (T1a, N0, M0); (T1b, N0, M0).  T1a: Lung cancer with a tumor size of 2 cm or less in greatest dimension, surrounded by lung or visceral pleura and without bronchoscopic evidence of invasion more proximal than the lobar bronchus (i.e., not in the main bronchus). The uncommon superficial tumor of any size with its invasive component limited to the bronchial wall, which may extend proximal to the main bronchus, is also classified as T1a.  T1b: Lung cancer with a tumor size more than 2 cm but 3 cm or less in greatest dimension, surrounded by lung or visceral pleura and without bronchoscopic evidence of invasion more proximal than the lobar bronchus (i.e., not in the main bronchus).  N0: No regional lymph metastasis.  M0: No distant metastasis. (AJCC 7th ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage IA Lung Non-Small Cell Carcinoma AJCC v7","conceptCode":"C5652","definition":"Stage IA includes: (T1a, N0, M0); (T1b, N0, M0).  T1a: Lung cancer with a tumor size of 2 cm or less in greatest dimension, surrounded by lung or visceral pleura and without bronchoscopic evidence of invasion more proximal than the lobar bronchus (i.e., not in the main bronchus). The uncommon superficial tumor of any size with its invasive component limited to the bronchial wall, which may extend proximal to the main bronchus, is also classified as T1a.  T1b: Lung cancer with a tumor size more than 2 cm but 3 cm or less in greatest dimension, surrounded by lung or visceral pleura and without bronchoscopic evidence of invasion more proximal than the lobar bronchus (i.e., not in the main bronchus).  N0: No regional lymph metastasis.  M0: No distant metastasis. (AJCC 7th ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"DC2367C9-0044-2766-E040-BB89AD437A4E","latestVersionIndicator":"Yes","beginDate":"2013-05-07","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-05-07","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"DC2367C9-005D-2766-E040-BB89AD437A4E","beginDate":"2013-05-07","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-05-07","modifiedBy":"ONEDATA","dateModified":"2013-05-07","deletedIndicator":"No"},{"value":"0","valueDescription":"Stage 0 Non-Small Cell Lung Cancer","ValueMeaning":{"publicId":"3745000","version":"1","preferredName":"Stage 0 Non-Small Cell Lung Cancer","longName":"3745000","preferredDefinition":"Stage 0 includes: Tis, N0, M0.  Tis: Carcinoma in situ.  N0: No regional lymph node metastasis.  M0: No distant metastasis. (AJCC 6th and 7th eds.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage 0 Lung Non-Small Cell Cancer AJCC v6 and v7","conceptCode":"C9104","definition":"Stage 0 includes: Tis, N0, M0.  Tis: Carcinoma in situ.  N0: No regional lymph node metastasis.  M0: No distant metastasis. (AJCC 6th and 7th eds.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"DC2367C9-006A-2766-E040-BB89AD437A4E","latestVersionIndicator":"Yes","beginDate":"2013-05-07","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-05-07","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"DC2367C9-0083-2766-E040-BB89AD437A4E","beginDate":"2013-05-07","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-05-07","modifiedBy":"ONEDATA","dateModified":"2013-05-07","deletedIndicator":"No"},{"value":"Occult","valueDescription":"Occult Non-Small Cell Lung Carcinoma","ValueMeaning":{"publicId":"3745002","version":"1","preferredName":"Occult Non-Small Cell Lung Carcinoma","longName":"3745002","preferredDefinition":"A non-small cell lung carcinoma detectable by sputum cytology only.  The primary tumor is undetectable radiographically or during bronchoscopy; therefore, it can not be assessed. (NCI05)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Occult Lung Non-Small Cell Carcinoma","conceptCode":"C9038","definition":"A non-small cell lung carcinoma detectable by sputum cytology only.  The primary tumor is undetectable radiographically or during bronchoscopy; therefore, it can not be assessed.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"DC2367C9-0090-2766-E040-BB89AD437A4E","latestVersionIndicator":"Yes","beginDate":"2013-05-07","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-05-07","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"DC2367C9-00A9-2766-E040-BB89AD437A4E","beginDate":"2013-05-07","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-05-07","modifiedBy":"ONEDATA","dateModified":"2013-05-07","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"3744983","version":"1","preferredName":"NSCLC American Joint Committee on Cancer Stage Grouping Stage","preferredDefinition":"A group of at least three distinct histological types of lung cancer, including squamous cell carcinoma, adenocarcinoma, and large cell carcinoma.  Non-small cell lung carcinomas have a poor response to conventional chemotherapy.  --2002:A group formed for the purpose of developing a system of clinical staging for cancer that is acceptable to the American medical profession and is compatible with other accepted classifications.:An assessment based on the combined evaluation of the patient's T stage, M stage, and N stage.:The extent of a cancer within the body, especially whether the disease has spread from the original site to other parts of the body.","longName":"C2926:C39315:C38027:C16899","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Lung Non-Small Cell Carcinoma","conceptCode":"C2926","definition":"A group of at least three distinct histological types of lung cancer, including non-small cell squamous cell carcinoma, adenocarcinoma, and large cell carcinoma. Non-small cell lung carcinomas have a poor response to conventional chemotherapy.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"American Joint Committee on Cancer","conceptCode":"C39315","definition":"A group formed for the purpose of developing a system of clinical staging for cancer that is acceptable to the American medical profession and is compatible with other accepted classifications.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Stage Grouping","conceptCode":"C38027","definition":"An assessment based on the combined evaluation of the patient's T stage, M stage, and N stage, as well as prognostic parameters for specific cancers.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Neoplasm Stage","conceptCode":"C16899","definition":"The extent of a cancer in the body.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"DC2367C8-FF2A-2766-E040-BB89AD437A4E","latestVersionIndicator":"Yes","beginDate":"2013-05-07","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-05-07","modifiedBy":"ONEDATA","dateModified":"2013-05-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"AJCC Based:Staging Criteria Based on American Joint Committee on Cancer System","workflowStatus":"RELEASED","registrationStatus":"Application","id":"DC2367C8-FF3B-2766-E040-BB89AD437A4E","latestVersionIndicator":"Yes","beginDate":"2013-05-07","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-05-07","modifiedBy":"COOPERM","dateModified":"2014-01-17","changeDescription":"Created for CRF Harmonization per request D.Reeves for Duke U. mc 5/6/13","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2192345","version":"1","longName":"Data Standards","context":"NCIP","ClassificationSchemeItems":[{"publicId":"2859963","version":"1","longName":"Standard CRFs","context":"NCIP"},{"publicId":"3434437","version":"1","longName":"Staging/Extent of Disease (by Disease)","context":"NCIP"},{"publicId":"3744891","version":"1","longName":"Lung (Non-Small Cell)","context":"NCIP"}]},{"publicId":"3461150","version":"1","longName":"Staging","context":"NCIP","ClassificationSchemeItems":[{"publicId":"3461151","version":"1","longName":"AJCC Edition 7","context":"NCIP"}]},{"publicId":"5188870","version":"1","longName":"BPV - Tumor Biospecimen Acquisition","context":"BBRB","ClassificationSchemeItems":[{"publicId":"5405791","version":"1","longName":"BPV - Tumor Biospecimen Acquisition","context":"BBRB"},{"publicId":"6736424","version":"1","longName":"Lung Clinical Data Entry","context":"BBRB"},{"publicId":"6736425","version":"1","longName":"Lung Local Path Review","context":"BBRB"}]},{"publicId":"5506111","version":"1","longName":"Lung","context":"MCL","ClassificationSchemeItems":[{"publicId":"7781146","version":"1","longName":"Lung PCA Pilot","context":"MCL"},{"publicId":"5858017","version":"1","longName":"Lung Core","context":"MCL"}]},{"publicId":"5574838","version":"1","longName":"Staging/Extent of Disease","context":"NCI Standards","ClassificationSchemeItems":[{"publicId":"10000596","version":"1","longName":"AJCC Edition 7","context":"NCI Standards"},{"publicId":"5777523","version":"1","longName":"Lung-NSC","context":"NCI Standards"}]},{"publicId":"6437797","version":"1","longName":"Pre-Cancer Atlas Pilot","context":"MCL","ClassificationSchemeItems":[{"publicId":"7001792","version":"1","longName":"Lung PCA Pilot","context":"MCL"}]}],"AlternateNames":[{"name":"NSCLC_AJCC_STG","type":"Context Short Name","context":"NRG"},{"name":"NRG","type":"USED_BY","context":"NRG"},{"name":"3745006v1.0:3744984v1.0","type":"USED_BY","context":"NRG"},{"name":"BBRB","type":"USED_BY","context":"BBRB"},{"name":"ajcc_7_lung_disease_stage","type":"MCL Alt Name","context":"MCL"},{"name":"MCL","type":"USED_BY","context":"MCL"}],"ReferenceDocuments":[{"name":"Disease Stage","type":"Preferred Question Text","description":"Disease Stage","url":null,"context":"NCI Standards"},{"name":"CRF Text 1","type":"Alternate Question Text","description":"Clinical Stage","url":null,"context":"NRG"},{"name":"BPV_GTEx","type":"BBRB Text","description":"Clinical tumor stage group (AJCC 7th Edition)","url":null,"context":"BBRB"},{"name":"MCL-PCA-Lung-1","type":"Alternate Question Text","description":"American Joint Committee on Cancer clinical group stage","url":null,"context":"MCL"},{"name":"MCL-Template Name","type":"Data Collection Template","description":"lung_v0_2021_08_25-metrics.xlsx","url":"https://mcl.nci.nih.gov/resources/standards/mcl-cdes","context":"MCL"}],"origin":"AJCC Based:Staging Criteria Based on American Joint Committee on Cancer System","workflowStatus":"RELEASED","registrationStatus":"Preferred Standard","id":"DC244A63-8BC9-AF4B-E040-BB89AD4329B6","latestVersionIndicator":"Yes","beginDate":"2013-05-07","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-05-07","modifiedBy":"COLBERTM","dateModified":"2021-09-13","changeDescription":"9/9/21 mr Added alt name, AQT, alt def, ref doc, CSI PCA Lung and MCL Lung Core Created for CRF Harmonization per request by D.Reeves for Duke U. mc 5/7/13","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}